PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Humanitas Clinical and Research Center IRCCS, Rozzano, Milan, Italy; Department of Pharmaceutical Sciences, University of Piemonte Orientale \'A. Avogadro,\' Novara, Italy; Molecular Immunology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Evaluative Epidemiology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, Tennessee; Thoracic Oncology Unit, Medical Oncology Department, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy; and Clinical Research Lab, Oncology Department, IRCCS Istituto di Ricerche Farmacologiche \'Mario Negri,\' Milan, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1152/physrev.00018.2020
?:doi
?:hasPublicationType
?:journal
  • Physiological reviews
is ?:pmid of
?:pmid
?:pmid
  • 32721181
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 16.184
?:rankingScore_hIndex
  • 306
is ?:relation_isRelatedTo_publication of
?:title
  • Immunometabolic Status of COVID-19 Cancer Patients.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all